01.30.25 -- How Biotech Academy In Rome Is Reshaping Workforce Readiness

Choosing the right Fill/Finish partner ensures drug safety and operational efficiency. A reliable partner minimizes risk, prevents contamination, and improves yield, ultimately saving costs. This webinar highlights four key questions to identify a quality-focused provider. Key takeaways include reducing risks while increasing yield, assessing partner quality, and understanding the value of an experienced partner in meeting therapeutic goals. Click here to learn more.

To understand biotech companies’ evolving geographic strategies and perceptions, Arriello recently commissioned a transatlantic survey among regulatory, safety, and quality directors at small/medium biotechs, with respondents in Ireland and North America.

Four experts share how scale-up, regulatory expectations, demand forecasting, and process validation all play a role in the success of a biologic when embarking upon the commercial manufacturing journey.

Discover essential strategies to prevent clinical trials from reaching a crisis while gaining a deeper understanding of the importance of addressing systemic issues early.

Aseptic processing ensures drug sterility, with filter integrity testing being critical. PUPSIT, a regulatory requirement in the EU, ensures filters remain undamaged and effective during manufacturing.

Learn how a Stage-Gate approach to technology transfer and biomanufacturing can help to mitigate risk while shortening cycle times throughout the project lifecycle.

Uncover how AI is transforming the biomanufacturing industry and how partnerships between pharmaceutical companies and academic institutions are poised to set the new standard.

Here, we describe three biosafety testing methods: in vitro adventitious virus (IVV), species-specific virus testing such as minute virus of mice (MVM), and mycoplasma.

If you are in the process of developing a complex or sensitive injectable drug, learn about containment solutions to mitigate your risks and help you get your drug to the patient faster.

Quality data for informed decision-making is well supported by a built-in network of lab digitization solutions and a commitment to the principles of data integrity.

Biomarkers are crucial for early diagnosis of neurodegenerative diseases. Learn about key protein biomarkers through an exploration of clinicopathologic correlations and measurement strategies.

Consider us for your labeling and re-labeling, secondary packaging, and kitting needs for preclinical studies, clinical trials, merger and acquisition activities, and blinded studies.

Our global R&D center for mammalian cell processes is based in the UK and sits alongside a custom manufacturing facility where we undertake highly specialized development and manufacturing services.

Scaling your drug product from concept to commercial supply requires having the expertise to ask the right questions about your end goals, from the start.

Gain insights into boosting efficiency, fostering innovation, and how integrated capabilities generate value for innovators.

Discover high-quality GMP manufacturing capabilities, featuring a state-of-the-art isolator-based filling platform and extensive fill-finish capacity for vials, syringes, and cartridges.

Leverage our flexible solutions and access to proprietary CHO-K1 cell lines in our state-of-the-art cGMP suites equipped with single-use and traditional stainless steel bioreactors.